Average Co-Inventor Count = 5.56
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (102 from 288 patents)
2. Abbvie Inc. (2 from 822 patents)
3. Elmore Patent Law Group, P.c. (1 from 1 patent)
4. Enata Pharmacueticals, Inc. (1 from 1 patent)
5. Enanta Pharmacueticals, Inc. (1 from 1 patent)
106 patents:
1. 12398147 - Macrocyclic spiropyrrolidine derived antiviral agents
2. 12384753 - 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
3. 12281140 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
4. 12018017 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
5. 12006291 - Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid
6. 11976084 - Spiropyrrolidine derived antiviral agents
7. 11958879 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
8. 11945824 - Heterocyclic compounds as anti-viral agents
9. 11919910 - Spiropyrrolidine derived antiviral agents
10. 11912714 - Spiropyrrolidine derived antiviral agents
11. 11858945 - Alkyne-containing antiviral agents
12. 11834436 - Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
13. 11718641 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
14. 11578097 - Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
15. 11560368 - Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof